Diabetic Gastroparesis Clinical Trials

A clinical trial is being conducted to assess the safety and efficacy of a treatment for patients with diabetic and non-diabetic gastroparesis.

0099 : A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gastroparesis.

METO-IN-004 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Men with symptoms associated with Diabetic Gastroparesis.

METO-IN-003 : A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Clinical Study to Evaluate the Efficacy and Safety of Metoclopramide Nasal Spray in Women with symptoms associated with Diabetic Gastroparesis.

Diabetic Gastroparesis creates feelings of bloating, nausea, vomiting and pain.

A phase 2, randomized, double-blind, placebo-controlled study to evaluate the safety and efficacy of RM -131 administered to patients with diabetic gastroparesis

A research study is evaluating an investigational drug for Diabetic Gastroparesis.

Now enrolling for a diabetic gastroparesis research study. For more information contact: Clinical Trials of Texas, Inc. 210-949-0122.

A research study is evaluating an investigational medication for the symptoms of Diabetic Gastroparesis.

We are enrolling volunteers for a clinical research study evaluating the safety and efficacy of an investigational drug for individuals with Diabetic Gastroparesis. Qualified participants must: Ages 18 to 75 Have Diabetes Type 1 or 2 at least 5 years Have symptoms of nausea or vomiting, abdominal pain, bloating or ...